Evidence map›Paper›PMID 27922641›Full record

ArticleTranslational psychiatry2016

IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.

Y Sade, L Toker, N Z Kara, H Einat, S Rapoport, D Moechars, G T Berry, Y Bersudsky, G Agam

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Lithium chloride suppresses ferroptosis of induced pluripotent stem cells with ApoE4/E4 from a sporadic Alzheimer's disease patient.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.European review for medical and pharmacological sciences · 2022
    Review
  10. What is the Role of Lithium in Epilepsy?Current neuropharmacology · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Y SadeDepartment of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
L TokerDepartment of Psychiatry and Centre for High-Throughput Biology, University of British Columbia Vancouver, BC, Canada.
N Z KaraDepartment of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
H EinatSchool of Behavioral Sciences, Tel Aviv-Yaffo Academic College, Tel Aviv, Israel.
S RapoportBrain Physiology and Metabolism Section, Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
D MoecharsJohnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium.
G T BerryMetabolism Program Division of Genetics, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.
Y BersudskyPsychiatry Research Unit, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
G AgamDepartment of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Academic College of Tel Aviv-Yafo · ILGeha Mental Health Center · ILBen-Gurion University of the Negev · ILBoston Children's Hospital · USNational Institutes of Health · USUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lithium is the prototype mood stabilizer but its mechanism is still unresolved. Two hypotheses dominate-the consequences of lithium's inhibition of inositol monophosphatase at therapeutically relevant concentrations (the 'inositol depletion' hypothesis), and of glycogen-synthase kinase-3. To further elaborate the inositol depletion hypothesis that did not decisively determine whether inositol depletion per se, or phosphoinositols accumulation induces the beneficial effects, we utilized knockout mice of either of two inositol metabolism-related genes-IMPA1 or SMIT1, both mimic several lithium's behavioral and biochemical effects. We assessed in vivo, under non-agonist-stimulated conditions,

Indexed as

AnimalsAntimanic AgentsAutophagyBehavior, AnimalBrainGlycogen Synthase Kinase 3InositolInositol 1,4,5-TrisphosphateLithium ChlorideMiceMice, Inbred StrainsMice, KnockoutPhosphatidylinositolsPhosphoric Monoester HydrolasesRNA, MessengerSymportersAntimanic AgentsGlycogen Synthase Kinase 3InositolInositol 1,4,5-TrisphosphateLithium Chloridemyo-inositol-1 (or 4)-monophosphatasePhosphatidylinositolsPhosphoric Monoester HydrolasesRNA, MessengerSLC5A3 protein, mouseSymporters

Identifiers

PMID27922641
PMCPMC5315558
OpenAlexW2560245467

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.